Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3812743 | Osteopathic Family Physician | 2013 | 10 Pages |
Abstract
The sheer numbers of patients with type 2 diabetes, a chronic illness with multifactorial pathophysiology, common comorbidities, exacerbated by an obesity epidemic and a lack of specialists to care for them may seem daunting. However, new treatment options and treatment guidelines that take a more comprehensive and holistic approach to patient care are creating new opportunities to improve glycemic control. Today's approach to the patient with type 2 diabetes is a balancing act between appropriate glucose lowering while avoiding hypoglycemia. Fortunately, the development, introduction, and integration of incretin-based therapies (GLP-1 receptor agonists and DPP-4 inhibitors) into combination treatment strategies have reduced the risks of hypoglycemia and weight gain of more traditional treatment approaches. This review article explores these topics for the osteopathic family physician.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Frank MD,